Authorized Generics And Pay-For-Delay Settlements
The focus of this article is the role of authorized generics ("AGs") in pay-for-delay settlements. The Federal Trade Commission recently approved staff's filing an amicus curiae brief in the matter of...To view the full article, register now.
Already a subscriber? Click here to view full article